Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines

Fitoterapia

Volumn 84, Issue 1, 2013, Pages 347-359

  Akl, Mohamed R ^a   Ayoub, Nehad M ^a   Abuasal, Bilal S ^a   Kaddoumi, Amal ^a   Sylvester, Paul W ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

Tocotrienol; Breast cancer; Cell cycle arrest; Phytochemicals; Sesamin

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; GAMMA TOCOTRIENOL; PROTEIN P16; PROTEIN P27; RETINOBLASTOMA PROTEIN; SESAMIN; TRANSCRIPTION FACTOR E2F1;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DETERMINATION; DRUG METABOLISM; DRUG POTENTIATION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMANS; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; CYCLINS; DIOXOLES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; E2F1 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGNANS; MICE; MOLECULAR STRUCTURE; RETINOBLASTOMA PROTEIN; VITAMIN E;

EID: 84873367867     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2012.12.013     Document Type: Article

References (41)

1. H.J. Burstein, S. Gelber, E. Guadagnoli, and J.C. Weeks Use of alternative medicine by women with early-stage breast cancer N Engl J Med 340 22 1999 1733 1739
2. L.G. Balneaves, J.L. Bottorff, T.G. Hislop, and C. Herbert Levels of commitment: exploring complementary therapy use by women with breast cancer J Altern Complement Med 12 5 2006 459 466
3. E. Crocetti The use of complementary therapies by breast cancer patients attending conventional treatment Eur J Cancer 34 3 1998 324 328
4. R.W. Rees Prevalence of complementary therapy use by women with breast cancer. A population-based survey Eur J Cancer 36 11 2000 1359 1364
5. H. Boon Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions J Clin Oncol 18 13 2000 2515 2521
6. A.M. Gross, Q. Liu, and S. Bauer-Wu Prevalence and predictors of complementary therapy use in advanced-stage breast cancer patients J Oncol Pract 3 6 2007 292 295
7. P.W. Sylvester, and A. Theriault Role of tocotrienols in the prevention of cardiovascular disease and breast cancer Curr Top Nutraceutical Res 1 2 2003 121 136
8. P.W. Sylvester Antiproliferative and apoptotic effects of tocotrienols on normal and neoplastic mammary epithelial cells R.R. Watson, V.R. Preedy, Tocotrienols: Vitamin E Beyond Tocopherols 2009 CRC Press Boca Raton 119 140
9. B.S. McIntyre Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells Lipids 35 2 2000 171 180
10. B.S. McIntyre, K.P. Briski, A. Gapor, and P.W. Sylvester Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells Proc Soc Exp Biol Med 224 4 2000 292 301
11. S.V. Bachawal, V.B. Wali, and P.W. Sylvester Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells Anticancer Res 30 2 2010 429 437
12. S.V. Bachawal, V.B. Wali, and P.W. Sylvester Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells BMC Cancer 10 2010 84
13. T.C. Hsieh, and J.M. Wu Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells Int J Oncol 33 4 2008 851 859
14. A.B. Shirode, and P.W. Sylvester Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling Biomed Pharmacother 64 2010 327 332
15. A.B. Shirode, and P.W. Sylvester Mechanisms mediating the synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment J Bioanal Biomed 3 2011 001 007 10.4172/1948-593X.1000036
16. V.B. Wali, and P.W. Sylvester Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells Lipids 42 12 2007 1113 1123
17. V.B. Wali, S.V. Bachawal, and P.W. Sylvester Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment Lipids 44 2009 925 934
18. V.B. Wali, S.V. Bachawal, and P.W. Sylvester Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1 Exp Biol Med (Maywood) 234 6 2009 639 650
19. S. Shah, A. Gapor, and P.W. Sylvester Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells Nutr Cancer 45 2 2003 236 246
20. N. Hirose Suppressive effect of sesamin against 7,12-dimethylbenz[a]- anthracene induced rat mammary carcinogenesis Anticancer Res 12 4 1992 1259 1265
21. T. Yokota Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells Cancer Sci 98 9 2007 1447 1453
22. C.C. Lee Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells Inflammation 34 3 2011 209 221
23. Ghafoorunissa, S. Hemalatha, and M.V. Rao Sesame lignans enhance antioxidant activity of vitamin E in lipid peroxidation systems Mol Cell Biochem 262 2004 195 202
24. C.S. You, T.J. Sontag, J.E. Swanson, and R.S. Parker Long-chain carboxychromanols are the major metabolites of tocopherols and tocotrienols in A549 lung epithelial cells but not HepG2 cells J Nutr 135 2005 227 232
25. Q. Jiang Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases Proc Natl Acad Sci U S A 105 2008 20464 20469
26. V.B. Wali, S.V. Bachawal, and P.W. Sylvester Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells Apoptosis 14 2009 1366 1377
27. P.W. Sylvester, A. Kaddoumi, S. Nazzal, and K.A. El Sayed The value of tocotrienols in the prevention and treatment of cancer J Am Coll Nutr 29 3 Suppl. 2010 324S 333S
28. P.W. Sylvester Tocotrienol combination therapy results in synergistic anticancer response Front Biosci 17 2011 3183 3195
29. Y. Wang, and R. Blelloch Cell cycle regulation by MicroRNAs in embryonic stem cells Cancer Res 69 10 2009 4093 4096
30. P.W. Sylvester Vitamin E and apoptosis Vitam Horm 76 2007 329 356
31. L.W. Anderson, K.G. Danielson, and H.L. Hosick New cell line. Epithelial cell line and subline established from premalignant mouse mammary tissue In Vitro 15 11 1979 841 843
32. L.W. Anderson, K.G. Danielson, and H.L. Hosick Metastatic potential of hyperplastic alveolar nodule derived mouse mammary tumor cells following intravenous inoculation Eur J Cancer Clin Oncol 17 9 1981 1001 1008
33. K.G. Danielson, L.W. Anderson, and H.L. Hosick Selection and characterization in culture of mammary tumor cells with distinctive growth properties in vivo Cancer Res 40 6 1980 1812 1819
34. P.W. Sylvester, H.P. Birkenfeld, H.L. Hosick, and K.P. Briski Fatty acid modulation of epidermal growth factor-induced mouse mammary epithelial cell proliferation in vitro Exp Cell Res 214 1 1994 145 153
35. S.J. Shah, and P.W. Sylvester Tocotrienol-induced cytotoxicity is unrelated to mitochondrial stress apoptotic signaling in neoplastic mammary epithelial cells Biochem Cell Biol 83 1 2005 86 95
36. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc Natl Acad Sci U S A 76 9 1979 4350 4354
37. S.J. Shah, and P.W. Sylvester Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity Exp Biol Med 230 4 2005 235 241
38. B. Abuasal, P.W. Sylvester, and A. Kaddoumi Intestinal absorption of gamma-tocotrienol is mediated by Niemann-Pick C1-like 1: in situ rat intestinal perfusion studies Drug Metab Dispos 38 2010 939 945
39. B.S. Abuasal, S. Thomas, P.W. Sylvester, and A. Kaddoumi Development and validation of a reversed-phase HPLC method for the determination of gamma-tocotrienol in rat and human plasma Biomed Chromatogr 25 2011 621 627
40. R.J. Tallarida Drug synergism: its detection and applications J Pharmacol Exp Ther 298 3 2001 865 872
41. M.R. Akl, N.M. Ayoub, and P.W. Sylvester Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment Planta Med 78 16 2012 1731 1739